Novocure reports FY25 preliminary net revenues of $655.4M
Seeking Alpha News (Mon, 12-Jan 11:34 AM ET)
Everus Names Kenny Whipple Vice President of Business Development
Business Wire (Mon, 17-Nov 8:30 AM ET)
Everus Reports Third Quarter Results, Raises Guidance for 2025
Business Wire (Tue, 4-Nov 4:30 PM ET)
Everus to Participate in Upcoming Investor Conferences
Business Wire (Fri, 31-Oct 8:30 AM ET)
Everus Construction Group to Hold Third Quarter Results Webcast Nov. 5
Business Wire (Wed, 22-Oct 4:30 PM ET)
Everus Construction Group Inc is a construction solutions provider, offering specialty contracting services to a diverse set of end markets across the U.S. It operates across two segments Electrical & Mechanical (E&M) and Transmission & Distribution (T&D), and delivers services through its subsidiaries. It generates the majority of revenue from the Electrical & Mechanical segment which offers a wide variety of specialty contracting services, including construction and maintenance of electrical and communication wiring, fire suppression systems, and mechanical piping and services, to customers in both the public and private sectors. Its T&D segment serves electric and natural gas utility customers, as well as customers in the transportation end market, in the West and Midwest regions.
Everus Construction Group trades on the NYSE stock market under the symbol ECG.
As of January 12, 2026, ECG stock price declined to $85.28 with 1,701,978 million shares trading.
ECG has a beta of 1.67, meaning it tends to be more sensitive to market movements. ECG has a correlation of 0.23 to the broad based SPY ETF.
ECG has a market cap of $4.35 billion. This is considered a Mid Cap stock.
Last quarter Everus Construction Group reported $987 million in Revenue and $1.11 earnings per share. This beat revenue expectation by $160 million and exceeded earnings estimates by $.49.
The top ETF exchange traded funds that ECG belongs to (by Net Assets): IJR, VTI, VB, AIRR, VXF.
ECG has outperformed the market in the last year with a return of +27.9%, while the SPY ETF gained +19.2%. However, in the most recent history, ECG shares have underperformed the stock market with its stock returning -2.8% in the last 3 month period and -5.3% for the last 2 week period, while SPY has returned +3.9% and +0.7%, respectively.
ECG support price is $82.36 and resistance is $88.30 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ECG shares will trade within this expected range on the day.